A Phase 1, Open-Label, Dose Finding, First-in-Human Study to Determine the Safety, Pharmacokinetics and Efficacy of KPG-121 when Administered with Enzalutamide, Abiraterone, or Apalutamide in Subjects with Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

IRB/UVA Tracking #
21998
Contact
Julio Torres
Contact Email
Contact Phone
1.434.982.4110
Phase
I
Primary purpose
Treatment
Cancer PI
Michael Devitt
Status
OPEN TO ACCRUAL
Ages
Adult